Awaited Ivermectin Review Is Out

Proponents of ivermectin for COVID-19 have long been talking about an expected review and meta-analysis led by Andrew Hill, PhD, of the University of Liverpool.

These results were finally published this week in Open Forum Infectious Diseases, and they're positive -- but they haven't escaped criticism, and most researchers still want results from a randomized controlled trial.